104 related articles for article (PubMed ID: 6832848)
1. Methods and mechanisms for the development of MTX resistance in human lymphoid cells.
Alam A; Geddes AJ; North AC
Int J Cancer; 1983 Jan; 31(1):45-50. PubMed ID: 6832848
[No Abstract] [Full Text] [Related]
2. Effects of methotrexate esters and other lipophilic antifolates on methotrexate-resistant human leukemic lymphoblasts.
Rosowsky A; Lazarus H; Yuan GC; Beltz WR; Mangini L; Abelson HT; Modest EJ; Frei E
Biochem Pharmacol; 1980 Feb; 29(4):648-52. PubMed ID: 6929188
[No Abstract] [Full Text] [Related]
3. Biochemical mechanisms of resistance to antimetabolites.
Harrap KR; Jackson RC
Antibiot Chemother (1971); 1978; 23():228-37. PubMed ID: 348081
[No Abstract] [Full Text] [Related]
4. In vitro activity of novel antifolates against human squamous carcinoma cell lines of the head and neck with inherent resistance to methotrexate.
van der Laan BF; Jansen G; Kathmann GA; Westerhof GR; Schornagel JH; Hordijk GJ
Int J Cancer; 1992 Jul; 51(6):909-14. PubMed ID: 1639538
[TBL] [Abstract][Full Text] [Related]
5. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
Diddens H; Niethammer D; Jackson RC
Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
[TBL] [Abstract][Full Text] [Related]
6. Acquired methotrexate resistance in lymphoblasts resulting from altered kinetic properties of dihydrofoltate reductase.
Jackson RC; Niethammer D
Eur J Cancer (1965); 1977 Jun; 13(6):567-75. PubMed ID: 880964
[No Abstract] [Full Text] [Related]
7. Resistance mechanisms to methotrexate in tumors.
Bertino JR; Göker E; Gorlick R; Li WW; Banerjee D
Stem Cells; 1996 Jan; 14(1):5-9. PubMed ID: 8820944
[TBL] [Abstract][Full Text] [Related]
8. Drug response, dihydrofolate reductase, and cytogenetics of amethopterin-resistant Chinese hamster cells in vitro.
Biedler JL; Albrecht AM; Hutchison DJ; Spengler BA
Cancer Res; 1972 Jan; 32(1):153-61. PubMed ID: 5007683
[No Abstract] [Full Text] [Related]
9. Resistance of human tumor cell lines to antifolates.
Diddens H; Niethammer D; Jackson RC
Cancer Treat Rev; 1984 Mar; 11 Suppl A():37-41. PubMed ID: 6234060
[No Abstract] [Full Text] [Related]
10. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
Chu BC; Fan CC; Howell SB
J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452
[TBL] [Abstract][Full Text] [Related]
11. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
[TBL] [Abstract][Full Text] [Related]
12. Two different species of dihydrofolate reductase in mammalian cells differentially resistant to amethopterin and methasquin.
Albrecht AM; Biedler JL; Hutchison DJ
Cancer Res; 1972 Jul; 32(7):1539-46. PubMed ID: 4402276
[No Abstract] [Full Text] [Related]
13. Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells.
Domin BA; Cheng YC; Hakala MT
Mol Pharmacol; 1982 Jan; 21(1):231-8. PubMed ID: 7132960
[No Abstract] [Full Text] [Related]
14. Comparison of the effects of methotrexate and pyrimethamine on L5178Y lymphoblasts in cell culture.
Goldie JH; Furness ME; Price LA
Eur J Cancer (1965); 1973 Oct; 9(10):709-15. PubMed ID: 4529729
[No Abstract] [Full Text] [Related]
15. Kinetic investigation of methotrexate resistant human dihydrofolate reductase (hDHFR) mutants at Phe31.
Chunduru SK; Appleman JR; Blakley RL
Adv Exp Med Biol; 1993; 338():507-10. PubMed ID: 8304168
[No Abstract] [Full Text] [Related]
16. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
Belur LR; James RI; May C; Diers MD; Swanson D; Gunther R; McIvor RS
J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949
[TBL] [Abstract][Full Text] [Related]
17. Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae.
Kündig C; Leblanc E; Papadopoulou B; Ouellette M
Nucleic Acids Res; 1999 Sep; 27(18):3653-9. PubMed ID: 10471733
[TBL] [Abstract][Full Text] [Related]
18. Recent concepts on the mechanism of action of methotrexate.
White JC
Cancer Treat Rep; 1981; 65 Suppl 1():3-12. PubMed ID: 7326663
[No Abstract] [Full Text] [Related]
19. Vriation of dihydrofolate reductase activity in mammalian cells in vitro.
Hillcoat BL; Bertino JR
Exp Cell Res; 1969 Aug; 56(2):304-8. PubMed ID: 5259181
[No Abstract] [Full Text] [Related]
20. Molecular mechanisms of cellular resistance to folate analogs.
Grzelakowska-Sztabert B
Prog Clin Biol Res; 1983; 132C():213-22. PubMed ID: 6634773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
